PERBANDINGAN HASIL MIKROSKOPIS LANJUTAN PENDERITA TBC PARU SETELAH PENGOBATAN DENGAN RIWAYAT DM DAN TANPA DM DI PUSKESMAS KEDUNDUNG
DOI:
https://doi.org/10.51804/jsh.v7i2.14355.68-72Abstract
Comorbid diabetes mellitus (DM) in pulmonary tuberculosis (TB) patients may increase the risk of death even with or during TB treatment. Immunocompromised conditions due to DM increase the risk of infection and sputum conversion failure. The risk of recurrence in comorbid patient is also higher after treatment. Objective of this research is to describe the comparison of further microscopic examination of pulmonary tuberculosis patients without DM and pulmonary tuberculosis patients with a history of diabetes at the Kedundung Public Health Center. The study was conducted by observing each of 15 TB positive sputum samples accompanied by a history of DM and those without any history of DM 2 months post-treatment on further microscopic examination. Further microscopic examination showed that 100% of sputum samples of TB patients without a history of DM and receiving treatment gave negative results, while sputum samples of TB patients with DM history and receiving treatment, while sputum samples of patients who had received treatment showed results of 2+ by 80% and 3+ by 20% and there were no negative results for TB. These results prove that there is an effect of a history of DM disease on TB treatment outcomes.
Keywords : Further microscopic examination, Pulmonary tuberculosis (TB), Diabetes Mellitus (DM)
References
Abdelbary, B. E., Garcia-Viveros, M., Ramirez-Oropesa, H., Rahbar, M. H., & Restrepo, B. I. 2016. Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico. Tuberculosis (Edinburgh, Scotland), 101S, S124–S134.
Afera, L.S., Santoso, S.D. dan Santosa, R.I., 2021. Rasio Albumin Kreatinin Urin Sebagai Deteksi Dini Gangguan Fungsi Ginjal pada Diabetes Melitus. Jurnal SainHealth. 5(2). 1-5
Akash, M.S.H., Rehman, K., Fiayyaz, F., Sabir, S., dan Khurshid, M.2020. Diabetes-Associated Infections: Development of Antimicrobial Resistance and Possible Treatment Strategies. Archives of Microbiology. 202: 953-965
Berbudi, A., Rahmadika, N., Tjahjadi, A.I. dan Ruslami, R. Type 2 Diabetes and Its Impact on The Immune System. Current Diabetes Reviews, 16: 442-449
Casqueiro J, Casqueiro J, dan Alves C 2012. Infections in patients withdiabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab16:S27–36
CDC. 2023. How to Tb Spread. Online. https://www.cdc.gov/tb.Diakses pada September 2023
Ekawati, E.R., Prayitno, D.S., Herawati, D., 2022., Sensitivitas dan Spesifikasi Deteksi Mycobacterium tuberculosisMetode Tes Cepat Molekuler Genexpert dengan Pemeriksaan Mikroskopis. Jurnal SainHealth. 6(2): 68-76
Farmani, P.I. 2022. Screening Tuberkulosis pada Pasien Diabetes Mellitus untuk Meningkatkan Case Notification Rate di Kota Denpasar. Jurnal Epidemiologi Kesehatan Komunitas. 7(2): 577-586
Magee, M.J., Foote,M., Howards, P.P., Narayan, K.M., Blumberg, H.M., Ray, S.M. dan Kempker, R.R. 2014. Diabetes Mellitus and Risk of All-Cause Mortality Among Patients with Tuberculosis in The State of Georgia, 2009-2012. Ann Epidemiol. 24(5): 369-375
Nagendra, L., Boro, H., dan Mannar, V. 2022. Bacterial Infections in Diabetes. Endotext. 2022:1-27
Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors amongtuberculosis patients in India. PLoS One 2012;7:e41367
World Health Organization. 2019. Global tuberculosis report 2019. Geneva, Switzerland
Yamagishi F, Suzuki K, Sasaki Y, Saitoh M, Izumizaki M, dan Koizumi K.. 1996 Prevalence of Coexisting Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis. Kekkaku71:569–572
Yanti, Z. 2017. Pengaruh Diabetes Melitus Terhadap Keberhasilan Pengobatan TB Paru di Puskesmas Tanah Kalikedinding. Jurnal Berkala Epidemiologi.5(2): 163-173.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Jurnal SainHealth
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal SainHealth is licensed under Creative Commons Attribution 4.0 International License.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
